Exploring Pass-y 90 Scores and Treatment Effectiveness in Psoriasis Patients

Comparing the efficacy of biologic and non-biologic systemic agents in achieving Pass-y 90 for patients with psoriasis, highlighting the superiority of biologic treatments. The chapter emphasizes the need for additional research on the long-term safety of these medications and the role of non-biologic systemic treatments in managing moderate to severe psoriasis.